arrow
返回
C

Changming Xia

regeneron pharmaceuticals inc.

0H指数
4论文数
0被引数
收录论文 4
发表时间
Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSIONDupilumab在儿科哮喘中的疗效与早期嗜酸性粒细胞状态:VOYAGE/EXCURSION研究的后期分析
err2026-06-30
err0
errOAAI
errSharon Dell; Theresa W. Guilbert; Antoine Deschildre; Wanda Phipatanakul; Nikolaos G. Papadopoulos; Clare S. Murray; Changming Xia; Andrew Moraco; Marissa Shams; Leonard B. Bacharier
err分享
err收藏
Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization LevelDupilumab在按过敏原致敏水平划分的未控制中重度2型哮喘儿童中的疗效
err2026-06-18
err0
errOAAI
errWanda Phipatanakul; Nikolaos G. Papadopoulos; Vivian Hernandez-Trujillo; Eckard Hamelmann; Robert S. Zeiger; Francine M. Ducharme; Changming Xia; Rebecca Gall; Olivier Ledanois; Amr Radwan; Juby A. Jacob-Nara; Paul J. Rowe; Yamo Deniz
err分享
err收藏
Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: a post hoc analysisDupilumab在LABA和ICS停药后仍保持哮喘患者的疗效:一项事后分析
err2026-04-18
err0
PREAI
errMichael E. Wechsler; Arnaud Bourdin; Klaus F. Rabe; Ian D. Pavord; J. Christian Virchow; Rohit Katial; Elliot Israel; Changming Xia; Olivier Ledanois; Mena Soliman; David J. Jackson
err分享
err收藏